Symbiotec Pharmalab IPO GMP, Grey Market Premium Today
Symbiotec Pharmalab IPO's GMP is ₹185 on September 1, 2026. If you add this to the IPO price, which is ₹988, you get an estimated listing price of ₹1173. This means there's a potential gain of 18.7% per share.The GMP is updated daily, and recently it's been towards the lower side.Keep an eye on daily updates to see how the IPO price is trending.
Last Updated - 1 September, 2026 7:57 pm
|
Check Live IPO GMP List 👈
|
| Listed |
Symbiotec Pharmalab IPO GMP Today is - ₹185
| IPO Price : | 988 Rs |
| IPO GMP : | 185 Rs 👈 |
| Expected Listing Price : | 988+185 = 1173 Rs |
| Expected IPO Gain %: | 18.7% 👈 |
| Lot Shares: | 15 |
| Lot Price: | 14,820 Rs |
| Lot Expected Profit: | 2,775 Rs |
Symbiotec Pharmalab IPO Expected Profit
| Number Of Lots | Lot Shares | Lot Price | Lot Profit | Lot Expected Listing |
|---|---|---|---|---|
| 1 | 15 | 14,820 Rs | 2,775 Rs | 17,595 Rs |
| 2 | 30 | 29,640 Rs | 5,550 Rs | 35,190 Rs |
| 3 | 45 | 44,460 Rs | 8,325 Rs | 52,785 Rs |
| 4 | 60 | 59,280 Rs | 11,100 Rs | 70,380 Rs |
| 5 | 75 | 74,100 Rs | 13,875 Rs | 87,975 Rs |
| 6 | 90 | 88,920 Rs | 16,650 Rs | 1,05,570 Rs |
| 7 | 105 | 1,03,740 Rs | 19,425 Rs | 1,23,165 Rs |
| 8 | 120 | 1,18,560 Rs | 22,200 Rs | 1,40,760 Rs |
| 9 | 135 | 1,33,380 Rs | 24,975 Rs | 1,58,355 Rs |
| 10 | 150 | 1,48,200 Rs | 27,750 Rs | 1,75,950 Rs |
| 11 | 165 | 1,63,020 Rs | 30,525 Rs | 1,93,545 Rs |
| 12 | 180 | 1,77,840 Rs | 33,300 Rs | 2,11,140 Rs |
| 13 | 195 | 1,92,660 Rs | 36,075 Rs | 2,28,735 Rs |
Symbiotec Pharmalab IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 24 August, 2026 |
| Close Date: | 27 August, 2026 |
| Allotment Date: | 28 August, 2026 |
| Refund Date: | 31 August, 2026 |
| Shares Credit Date: | 31 August, 2026 |
| Listing Date: | 1 September, 2026 |
Symbiotec Pharmalab IPO GMP Grey Market Premium FAQs
Q.What is Symbiotec Pharmalab IPO GMP Today?
Ans.Symbiotec Pharmalab IPO GMP is ₹185 as of today.
Q.What is Symbiotec Pharmalab IPO Expected Returns?
Ans.Symbiotec Pharmalab IPO Expected Returns is 18.7%.